Back to today’s briefing

Story perspectives

Dr. Prasad Resigns from FDA Amid Drug Approval Controversy

8/1/2025

45 4

Summary

Story summary

Dr. Vinay Prasad stepped down from his FDA role after just three months, facing intense scrutiny from right-wing critics like Laura Loomer. Accusations of stalling drug approvals, especially for Sarepta Therapeutics’ Elevidys, intensified the backlash against his liberal stance, underscoring the clash between personal beliefs and the demands of public health policy.

1 of 1

Story summary

Dr. Vinay Prasad stepped down from his FDA role after just three months, facing intense scrutiny from right-wing critics like Laura Loomer. Accusations of stalling drug approvals, especially for Sarepta Therapeutics’ Elevidys, intensified the backlash against his liberal stance, underscoring the clash between personal beliefs and the demands of public health policy.